share price:

10430

Gedeon Richter is a specialised, innovation-driven pharmaceutical company committed to supporting society in the fight against disease by developing and delivering modern therapies.

Learn more

A specialised pharmaceutical company
Gedeon Richter’s strategic objective is to strengthen its position among Europe’s leading mid-sized pharmaceutical companies.

Areas of Expertise

Areas of Activity

Gedeon Richter focuses on creating high value-added products, basing its strategy on innovative research and placing a strong emphasis on women’s health and the development of biosimilar medicines.

Learn more

Research into new molecules has always been at the core of Gedeon Richter’s corporate strategy. The company’s research and development centre, employing more than 1,200 people, makes it the leading pharmaceutical research hub in Central and Eastern Europe.

Our Products

Gedeon Richter’s portfolio includes over 200 original, generic and licensed therapies used across a wide range of therapeutic areas. The company focuses on developing and manufacturing medicines used in the treatment of disorders of the nervous system, cardiovascular diseases and gynaecology.

Learn more

Thanks to its in-house production of active pharmaceutical ingredients and a broad product portfolio, Richter delivers innovative therapeutic solutions for women of all ages and   with diverse health needs.

Sustainability

At Gedeon Richter, we continuously pursue innovation. At the same time, we believe that through conscious and responsible actions, we can meet the needs of today’s generations while maintaining the trust of those to come.

Learn more

We are proud that Gedeon Richter represents not only innovative products, but also a stable and supportive workplace guided by the principles of sustainable development.

Contact

If you have any questions, please contact us using the appropriate telephone number or email address.

If you have not found the information you were looking for on our website or have additional questions, we encourage you to get in touch with us.

Groprinosin Max

Układ krążenia Układ nerwowy Cardiology Gynaecology and endocrinology Neurology Infectious diseases Musculoskeletal system Urology Gastroenterology Dermatology Psychiatry

Active substance:

Inosinum pranobexum

Dosage:

250 mg/ml

Therapeutic area:

Infectious diseases

Pharmaceutical form:

Oral drops, solution

Product category:

Bez recepty

Refund:

Brochure Groprinosin Max

Driving a car

Yes

Breast feeding

Taking on an empty stomach

Yes

Drug storage

Nie przechowywać w lodówce ani nie zamrażać. Przechowywać w oryginalnym opakowaniu w celu ochrony przed światłem. w temp. poniżej 25

Download full drug leaflet

PDF

Communicable diseases, also referred to as infectious diseases, are one of the most numerous groups of conditions that affect humans irrespective of age, sex, skin colour and geographical latitude.

See other products from the area

About us

Areas of Activity

Our Products

Sustainability

Contact

Groprinosin Max

Brochure Groprinosin Max

Infectious diseases

Identity confirmation

Charakterystyka produktu leczniczego

Groprinosin Max

Do pobrania

Brochure Groprinosin Max

Infectious diseases

Identity confirmation

Charakterystyka produktu leczniczego